169 related articles for article (PubMed ID: 20969767)
1. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
Lee CK; Lee JH; Lee MG; Jeong SI; Ha TK; Kang MJ; Ryu BK; Hwangbo Y; Shim JJ; Jang JY; Lee KY; Kim HJ; Chi SG
BMC Cancer; 2010 Oct; 10():577. PubMed ID: 20969767
[TBL] [Abstract][Full Text] [Related]
2. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.
Hesson L; Dallol A; Minna JD; Maher ER; Latif F
Oncogene; 2003 Feb; 22(6):947-54. PubMed ID: 12584574
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
[TBL] [Abstract][Full Text] [Related]
4. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.
Avruch J; Praskova M; Ortiz-Vega S; Liu M; Zhang XF
Methods Enzymol; 2006; 407():290-310. PubMed ID: 16757333
[TBL] [Abstract][Full Text] [Related]
5. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.
Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP
Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544
[TBL] [Abstract][Full Text] [Related]
6. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
Irimia M; Fraga MF; Sanchez-Cespedes M; Esteller M
Oncogene; 2004 Nov; 23(53):8695-9. PubMed ID: 15378027
[TBL] [Abstract][Full Text] [Related]
7. Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases.
Aoyama Y; Avruch J; Zhang XF
Oncogene; 2004 Apr; 23(19):3426-33. PubMed ID: 15007383
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
9. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
Macheiner D; Heller G; Kappel S; Bichler C; Stättner S; Ziegler B; Kandioler D; Wrba F; Schulte-Hermann R; Zöchbauer-Müller S; Grasl-Kraupp B
J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329
[TBL] [Abstract][Full Text] [Related]
10. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
[TBL] [Abstract][Full Text] [Related]
11. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekström TJ; Farnebo F; Larsson C
Int J Cancer; 2008 Jul; 123(2):389-394. PubMed ID: 18452173
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.
Lorente A; Mueller W; Urdangarín E; Lázcoz P; Lass U; von Deimling A; Castresana JS
Brain Pathol; 2009 Apr; 19(2):279-92. PubMed ID: 18616639
[TBL] [Abstract][Full Text] [Related]
13. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung.
Vos MD; Martinez A; Ellis CA; Vallecorsa T; Clark GJ
J Biol Chem; 2003 Jun; 278(24):21938-43. PubMed ID: 12676952
[TBL] [Abstract][Full Text] [Related]
14. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
Djos A; Martinsson T; Kogner P; Carén H
Mol Cancer; 2012 Jun; 11():40. PubMed ID: 22695170
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors.
Nakamura N; Carney JA; Jin L; Kajita S; Pallares J; Zhang H; Qian X; Sebo TJ; Erickson LA; Lloyd RV
Lab Invest; 2005 Sep; 85(9):1065-75. PubMed ID: 15980887
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
18. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses.
Chung SK; Lee MG; Ryu BK; Lee JH; Han J; Byun DS; Chae KS; Lee KY; Jang JY; Kim HJ; Chi SG
Gastroenterology; 2007 Jun; 132(7):2459-77. PubMed ID: 17570219
[TBL] [Abstract][Full Text] [Related]
19. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.
Foukakis T; Au AY; Wallin G; Geli J; Forsberg L; Clifton-Bligh R; Robinson BG; Lui WO; Zedenius J; Larsson C
J Clin Endocrinol Metab; 2006 Mar; 91(3):1143-9. PubMed ID: 16352687
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
